Alpha 2.0
Login Register
» Articles » PMID: 12039920

Thalidomide in Solid Malignancies

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2002 Jun 1
PMID 12039920
Citations 4
Authors
Tim Eisen
Affiliations
Soon will be listed here.
Citing Articles

Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report.

Raphael C, Hudson E, Williams L, Lester J, Savage P J Med Case Rep. 2010; 4:413.

PMID: 21176188 PMC: 3022673. DOI: 10.1186/1752-1947-4-413.

Resolving a double standard for risk management of thalidomide: an evaluation of two different risk management programmes in Japan.

Ooba N, Sato T, Watanabe H, Kubota K Drug Saf. 2009; 33(1):35-45.

PMID: 20000865 DOI: 10.2165/11318920-000000000-00000.

Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study.

Kerst J, Bex A, Mallo H, Dewit L, Haanen J, Boogerd W Cancer Immunol Immunother. 2005; 54(9):926-31.

PMID: 15906025 PMC: 11032798. DOI: 10.1007/s00262-005-0677-2.

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.

Bartlett J, Michael A, Clarke I, Dredge K, Nicholson S, Kristeleit H Br J Cancer. 2004; 90(5):955-61.

PMID: 14997189 PMC: 2410215. DOI: 10.1038/sj.bjc.6601579.